We are live on !
Find out more
Profund Advisors Portfolio holdings
AUM
$3.48B
Turnover
14.37%
1-Year Est. Return
66.96%
ProFund Advisors manages the ProFunds mutual funds, which include index funds across sectors, bonds, currencies and crypto, as well as leveraged and inverse funds. The ProFunds brand dates from 1997, and its affiliate ProShares began offering leveraged and inverse ETFs in 2006. The Bitcoin ProFund tracks bitcoin futures rather than holding bitcoin itself.
This Fund
S&P 500
This Quarter Est. Return
+3.6%
1 Year Est. Return
+66.96%
3 Year Est. Return
+258.11%
5 Year Est. Return
+342.15%
10 Year Est. Return
+1,333.1%
AUM
$3.48B
AUM Growth
-$153M
(-4.2%)
Cap. Flow
-$155M
Cap. Flow % of AUM
Cap. Flow %
-4.44%
Top 10 Holdings %
Top 10 Hldgs %
41.36%
Holding
1,225
New
50
Increased
319
Reduced
729
Closed
126
Avg Time Held
6.2
years
Top 10 Avg Time Held
4.5
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$37.8M |
| 2 |
Alumis Inc
ALMS
|
+$2.98M |
| 3 |
Collegium Pharmaceutical
COLL
|
+$1.65M |
| 4 |
Reddit
RDDT
|
+$1.57M |
| 5 |
Septerna Inc
SEPN
|
+$1.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$46.8M |
| 2 |
Broadcom
AVGO
|
+$15.2M |
| 3 |
Micron Technology
MU
|
+$13.3M |
| 4 |
Apple
AAPL
|
+$12.8M |
| 5 |
Advanced Micro Devices
AMD
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 54.2% |
| 2 | Healthcare | 10.88% |
| 3 | Communication Services | 8.15% |
| 4 | Consumer Discretionary | 7.38% |
| 5 | Industrials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
US Bancorp
USB
$94.2B
| $925K | 0.03% |
16,009
+1,232
| +8% | +$76.9K |
2013 Q2
53 quarters
|
|
377
Motorola Solutions
MSI
$87.7B
| $922K | 0.03% |
2,068
-261
| -11% | -$117K |
2016 Q3
40 quarters
|
|
378
CME Group
CME
$113B
| $916K | 0.03% |
3,498
+331
| +10% | +$87.3K |
2013 Q2
53 quarters
|
|
379
Elevance Health
ELV
$92.9B
| $916K | 0.03% |
2,355
-64
| -3% | -$25.5K |
2013 Q2
53 quarters
|
|
380
PNC Financial Services
PNC
$91.8B
| $912K | 0.03% |
4,104
+306
| +8% | +$75K |
2013 Q2
53 quarters
|
|
381
Vera Therapeutics
VERA
$2.1B
| $912K | 0.03% |
28,237
-8,825
| -24% | -$309K |
2023 Q3
12 quarters
|
|
382
VeriSign
VRSN
$28B
| $912K | 0.03% |
3,233
-388
| -11% | -$110K |
2013 Q2
53 quarters
|
|
383
Nektar Therapeutics
NKTR
$1.27B
| $909K | 0.03% |
15,021
+9,852
| +191% | +$692K |
2026 Q1
2 quarters
|
|
384
Aquestive Therapeutics
AQST
$449M
| $906K | 0.03% |
195,758
+163,019
| +498% | +$724K |
2025 Q4
3 quarters
|
|
385
Summit Therapeutics
SMMT
$12.1B
| $904K | 0.03% |
53,459
-47,090
| -47% | -$704K |
2024 Q1
10 quarters
|
|
386
International Flavors & Fragrances
IFF
$20.1B
| $902K | 0.03% |
10,808
-4,076
| -27% | -$336K |
2013 Q2
53 quarters
|
|
387
Aclaris Therapeutics
ACRS
$634M
| $902K | 0.03% |
171,421
+140,935
| +462% | +$805K |
2026 Q2
1 quarter
|
|
388
Royal Caribbean
RCL
$86.1B
| $898K | 0.03% |
3,378
+64
| +2% | +$18.2K |
2023 Q1
14 quarters
|
|
389
Robinhood
HOOD
$73.3B
| $894K | 0.03% |
7,949
+815
| +11% | +$86.5K |
2025 Q3
4 quarters
|
|
390
Nutanix
NTNX
$16.6B
| $894K | 0.03% |
12,698
-686
| -5% | -$43.1K |
2021 Q2
21 quarters
|
|
391
Arcus Biosciences
RCUS
$2.56B
| $893K | 0.03% |
34,584
-4,948
| -13% | -$140K |
2023 Q1
14 quarters
|
|
392
Phathom Pharmaceuticals
PHAT
$506M
| $886K | 0.03% |
121,331
+104,054
| +602% | +$981K |
2025 Q3
4 quarters
|
|
393
BioCryst Pharmaceuticals
BCRX
$1.98B
| $881K | 0.03% |
105,767
-28,267
| -21% | -$266K |
2023 Q1
14 quarters
|
|
394
Sarepta Therapeutics
SRPT
$1.72B
| $881K | 0.03% |
48,340
-17,348
| -26% | -$325K |
2018 Q3
32 quarters
|
|
395
BP
BP
$118B
| $881K | 0.03% |
20,017
+2,153
| +12% | +$92.4K |
2013 Q2
53 quarters
|
|
396
Quanta Services
PWR
$91.3B
| $874K | 0.03% |
1,361
-189
| -12% | -$122K |
2023 Q1
14 quarters
|
|
397
Agios Pharmaceuticals
AGIO
$1.9B
| $872K | 0.03% |
26,219
-2,041
| -7% | -$71.4K |
2023 Q1
14 quarters
|
|
398
IonQ
IONQ
$14.3B
| $870K | 0.03% |
+19,831
| New | +$804K |
2026 Q3
0 quarters
|
|
399
General Motors
GM
$72.8B
| $868K | 0.02% |
11,269
-134
| -1% | -$11.2K |
2013 Q2
53 quarters
|
|
400
Trane Technologies
TT
$92.8B
| $866K | 0.02% |
1,915
-303
| -14% | -$139K |
2013 Q2
53 quarters
|
|
Similar funds
TC
Profund Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, Profund Advisors held 1,225 positions worth $3.48B, down 4.2% from $3.64B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Profund Advisors withdrew a net $155M in Q3 2026, closing 126 positions and reducing 729 holdings. Its most notable exit was Electronic Arts, an estimated $5.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 54% of assets, down from 56% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Profund Advisors opened a new position in SpaceX worth $41.3M.
- Profund Advisors's largest Q3 2026 buy was SpaceX: 273,453 shares worth $41.3M.
- Profund Advisors added most to Alumis Inc in Q3 2026, an estimated $2.98M increase.
- Profund Advisors's biggest Q3 2026 reduction was NVIDIA, cutting an estimated $46.8M.
- Profund Advisors fully exited Electronic Arts in Q3 2026, selling an estimated $5.2M.
- Profund Advisors's ten largest holdings make up 41% of its $3.48B portfolio in Q3 2026.
- Profund Advisors opened 50 new positions and closed 126 in Q3 2026.
- Profund Advisors's portfolio value fell 4.2% quarter-over-quarter to $3.48B.
Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.